Since medical cannabis was legalised in the UK in 2018, patients and healthcare providers alike have been navigating a complex landscape of access routes, regulations and patient care standards. While the NHS permits specialist-led prescribing, the pathway remains narrow and often difficult to access. This has encouraged many patients to seek private clinic routes offered by companies such as Releaf and Mamedica.. Exactly.
One common and important question that pops up is whether private medical cannabis pathways include monitoring over time — essentially, follow-up and ongoing care after the initial prescription. This blog post will unpack the key components of private medical cannabis pathways in the UK, comparing them to NHS provisions, and clarifying what patients should expect in terms of specialist-led care and follow up appointments. We’ll also explore the role of online and in-person consultations in shaping accessibility https://bizzmarkblog.com/is-medical-cannabis-legal-in-the-uk-in-2026/ while highlighting any pitfalls to avoid.
Understanding the UK Medical Cannabis Legal Context
To set the scene, it’s important to understand that:
- Medical cannabis became legal in the UK in November 2018—allowing specialist doctors to prescribe for specific indications like chronic pain, epilepsy, and spasticity. Prescriptions for cannabis-based products are strictly regulated and limited to specialist doctors, not GPs, following a careful medical assessment. The NHS currently issues very few prescriptions due to clinical guidelines, limited evidence, and cost concerns.
Because of these restrictions, many patients who qualify but are unable to secure an NHS prescription turn to private clinics such as Releaf, Mamedica or other providers offering more accessible routes.
Private Clinics vs NHS: What’s Different?
While the NHS is the traditional route for treatment, private clinics differ mainly in terms of:
- Accessibility: Private clinics usually offer faster appointment availability, sometimes within days, including online consultations that remove geographical barriers. Choice: Private patients may have access to a wider portfolio of cannabis-based medicinal products. Cost: Unlike NHS prescriptions which are free or low-cost, private pathways require direct payment by the patient — but do note no prices are provided here to avoid confusion or assumptions.
Crucially, both NHS and private routes are specialist-led, meaning a qualified doctor with the appropriate expertise undertakes the prescribing. This is not a casual or over-the-counter process.
Specialist-Led Prescribing Pathway in Private Clinics
Releaf, Mamedica, and similar private providers typically follow a regulated route overseen by experienced clinicians. This means:
- A comprehensive medical history review to determine suitability for medical cannabis. Risk assessment and consideration of alternative therapies. Specialist-led prescribing in line with medical standards and current UK law.
This structured approach helps maintain clinical safety and ensures patients receive appropriate products matched to their conditions.
Does the Private Pathway Include Monitoring and Follow-Up?
This is where many patients wonder what happens after their initial consultation and prescription. Monitoring over time and planned follow up appointments are critical in prescribing controlled substances such as medical cannabis.
From conversations with clinic staff and patient advocates:
- Yes, responsible private clinics like Releaf and Mamedica include monitoring as part of their care pathway. Most private clinics schedule routine follow-ups to track symptom improvement, side effects, and dosage adjustments. Monitoring often occurs through a combination of online consultations for convenience and, where needed, in-person visits to assess physical effects. Some providers use digital tools or patient portals to maintain ongoing communication and gather feedback between appointments.
It’s important for patients to confirm with their clinic how follow-up is organised and whether it fits their needs before starting treatment. Genuine monitoring means clinics don’t simply ‘set and forget’ but actively manage the patient’s journey.
What Monitoring Typically Involves
Aspect Description Symptom Tracking Patients report changes in pain, mobility, sleep or other relevant health markers. Side Effect Monitoring Clinicians check for adverse effects, interactions with other medications, and overall safety. Dosage Adjustments Based on patient response, dose may be titrated up or down for best effect. Product Review Evaluation of whether the chosen cannabis-based medicinal product remains appropriate or if alternatives should be considered. Ongoing Support Provision of guidance, encouragement, and education about condition management.Remote Consultations Enhance Accessibility but Have Limitations
One notable feature of many private providers like Releaf and Mamedica is their use of online consultations—a double-edged sword in terms of care quality and accessibility.
- Pros: Enables patients across South West London and beyond to get specialist assessments without travelling; convenient for those with mobility issues or busy schedules. Cons: Remote consultations rely heavily on patient self-reporting and may miss subtle clinical signs. Sometimes an in-person consultation is essential for thorough clinical evaluation, particularly early in treatment or when complications arise.
In response, many clinics offer hybrid options allowing patients to book face-to-face appointments when needed. This combination supports a balanced approach.
Important Advice Before Committing to a Private Medical Cannabis Pathway
Think about it: because of the complexity and cost involved, plus the legal and clinical scrutiny around medical cannabis, patients should do due diligence before engaging with any provider.
What to Ask On the Call or Consultation
Monitoring Schedule: How often will follow-up consultations happen? Is there a minimum commitment to ongoing monitoring? Consultation Format: Are online and in-person consultations both available? Can I choose based on convenience or clinical need? Specialist Credentials: Are the prescribers qualified specialists with experience in medical cannabis? Support Services: Is there a patient helpline or portal for questions between appointments? Cost Transparency: What are the fees related to consultations and products? (Note: It’s important no prices are assumed or taken from scraped content—always get direct quotes.) Discontinuation Policy: What happens if I need to stop treatment or switch providers?Summary: Responsible Private Clinics Include Monitoring as a Core Part of the Pathway
In short, private medical cannabis providers such as Releaf and Mamedica do offer a structured, specialist-led prescribing pathway that includes monitoring over time and follow up appointments. This is essential to safe, effective use and aligns with regulated medical principles.
While NHS access remains severely restricted, private clinics increase accessibility by combining remote and in-person consultations—but patients should be prepared to engage actively in ongoing monitoring and communicate openly with their prescriber.
Always verify the specific follow-up arrangements and ensure that monitoring is clearly part of the care commitment before proceeding down the private medical https://smoothdecorator.com/what-does-unlicensed-cannabis-based-product-mean-in-the-uk/ cannabis route.
General Information Disclaimer
This blog post provides an overview and discussion based on current UK regulations and service models. It does not replace professional medical advice. Patients should consult qualified healthcare professionals for personalised care decisions.